title: Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
authors.affiliation: Department of Surgery, University of Erlangen-Nuremberg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Ott
authors.forename: S
authors.initials: S
authors.lastname: Gralka
authors.forename: R
authors.initials: R
authors.lastname: Froschauer
authors.forename: G
authors.initials: G
authors.lastname: Born
authors.forename: V
authors.initials: V
authors.lastname: Müller
authors.forename: T
authors.initials: T
authors.lastname: Reck
authors.forename: W
authors.initials: W
authors.lastname: Hohenberger
authors.forename: F
authors.initials: F
authors.lastname: Köckerling
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006509:Hepatitis B / Q000601:surgery; D006526:Hepatitis C / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D008103:Liver Cirrhosis / Q000601:surgery; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000453:epidemiology; D008775:Methylprednisolone / Q000627:therapeutic use; D015166:Monitoring, Immunologic; D016609:Neoplasms, Second Primary / Q000453:epidemiology; D009894:Opportunistic Infections / Q000453:epidemiology; D011183:Postoperative Complications; D012189:Retrospective Studies
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone